Takeda Pharmaceutical Company Limited Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised
Takeda Pharmaceutical Company Limited (TAK) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of JPY 427.37 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Income Taxes
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2025-06-25
- 2025-03-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 427.37B JPY.
- 2024-03-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 263.14B JPY.
- 2023-03-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 259.78B JPY.
- 2022-03-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 240.86B JPY.
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised |
|---|---|
| 2025-03-31 | 427.37B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 263.14B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 259.78B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 240.86B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 241.20B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 333.34B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 45.13B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 11.59B JPY 20-F · filed 2019-06-27 |